von Eschenbach AC - Search Results

1

Immunotherapy of murine renal adenocarcinoma by systemic administration of liposomes containing the synthetic macrophage activator CGP 31362 or CGP 19835A in combination with interleukin 2 or gamma-interferon.

Dinney CP, Utsugi T, Fidler IJ, von Eschenbach AC, Killion JJ. Dinney CP, et al. Among authors: von eschenbach ac. Cancer Res. 1992 Mar 1;52(5):1155-61. Cancer Res. 1992. PMID: 1531322

2

In vivo modulation of macrophage tumoricidal activity by oral administration of the liposome-encapsulated macrophage activator CGP 19835A.

Tanguay S, Bucana CD, Wilson MR, Fidler IJ, von Eschenbach AC, Killion JJ. Tanguay S, et al. Among authors: von eschenbach ac. Cancer Res. 1994 Nov 15;54(22):5882-8. Cancer Res. 1994. PMID: 7954418

3

Human recombinant interferons-beta and -gamma decrease gelatinase production and invasion by human KG-2 renal-carcinoma cells.

Gohji K, Fidler IJ, Tsan R, Radinsky R, von Eschenbach AC, Tsuruo T, Nakajima M. Gohji K, et al. Among authors: von eschenbach ac. Int J Cancer. 1994 Aug 1;58(3):380-4. doi: 10.1002/ijc.2910580313. Int J Cancer. 1994. PMID: 8050821

4

Regulation of gelatinase production in metastatic renal cell carcinoma by organ-specific fibroblasts.

Gohji K, Nakajima M, Fabra A, Bucana CD, von Eschenbach AC, Tsuruo T, Fidler IJ. Gohji K, et al. Among authors: von eschenbach ac. Jpn J Cancer Res. 1994 Feb;85(2):152-60. doi: 10.1111/j.1349-7006.1994.tb02076.x. Jpn J Cancer Res. 1994. PMID: 8144397 Free PMC article.

5

The development of liposomes containing interferon alpha for the intravesical therapy of human superficial bladder cancer.

Frangos DN, Killion JJ, Fan D, Fishbeck R, von Eschenbach AC, Fidler IJ. Frangos DN, et al. Among authors: von eschenbach ac. J Urol. 1990 Jun;143(6):1252-6. doi: 10.1016/s0022-5347(17)40248-5. J Urol. 1990. PMID: 2342197

6

Binding of liposomes to human bladder tumor epithelial cell lines: implications for an intravesical drug delivery system for the treatment of bladder cancer.

Johnson JW, Nayar R, Killion JJ, von Eschenbach AC, Fidler IJ. Johnson JW, et al. Among authors: von eschenbach ac. Sel Cancer Ther. 1989 Winter;5(4):147-55. doi: 10.1089/sct.1989.5.147. Sel Cancer Ther. 1989. PMID: 2623380

7

Therapy of spontaneous lung metastasis of murine renal adenocarcinoma by systemic administration of liposomes containing the macrophage activator CGP 31362.

Dinney CP, Bucana CD, Utsugi T, Fidler IJ, von Eschenbach AC, Killion JJ. Dinney CP, et al. Among authors: von eschenbach ac. Cancer Res. 1991 Jul 15;51(14):3741-7. Cancer Res. 1991. PMID: 1905975

8

Preoperative radiotherapy for muscle-invasive bladder carcinoma. Long term follow-up and prognostic factors for 338 patients.

Pollack A, Zagars GK, Dinney CP, Swanson DA, von Eschenbach AC. Pollack A, et al. Among authors: von eschenbach ac. Cancer. 1994 Nov 15;74(10):2819-27. doi: 10.1002/1097-0142(19941115)74:10<2819::aid-cncr2820741013>3.0.co;2-l. Cancer. 1994. PMID: 7954243 Clinical Trial.

9

Correlation of metastasis-related gene expression with metastatic potential in human prostate carcinoma cells implanted in nude mice using an in situ messenger RNA hybridization technique.

Greene GF, Kitadai Y, Pettaway CA, von Eschenbach AC, Bucana CD, Fidler IJ. Greene GF, et al. Among authors: von eschenbach ac. Am J Pathol. 1997 May;150(5):1571-82. Am J Pathol. 1997. PMID: 9137084 Free PMC article.

10

The biology of renal cancer: the influence of nephrectomy.

von Eschenbach AC, Avallone A, Price J, Swanson D, Killion J, Stephenson R, Fidler IJ. von Eschenbach AC, et al. Eur Urol. 1990;18 Suppl 2:40-1. doi: 10.1159/000463961. Eur Urol. 1990. PMID: 2226608 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

193 results

Search Page

Filters